HERLIAWATI, P. A. .; HARNANDARI, D. E. P. .; HILDAYANTI, R. A. .; WICAKSANA, A. .; FIRSTA, P. P. . Malignancy Risk Index 4 (RMI 4) is better than RMI 3 as a predictor Advanced Epithelial Ovarian Carcinoma was used for NACT. Jurnal Ners, [S. l.], v. 7, n. 1, p. 536–542, 2023. DOI: 10.31004/jn.v7i1.13495. Disponível em: http://journal.universitaspahlawan.ac.id/index.php/ners/article/view/13495. Acesso em: 3 jul. 2024.